ITB vs VHT
iShares US Home Construction ETF vs Vanguard Health Care ETF
- • VHT has the lower expense ratio at 0.09% vs 0.37% for ITB.
- • ITB pays a higher dividend yield (1.36%).
Side-by-side metrics
| Metric | ITB | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.37% | 0.09% |
Dividend yield Trailing 12-month yield. | 1.36% | 1.35% |
AUM Assets under management — bigger funds are typically more liquid. | $2.37B | $23.73B |
YTD return | 4.51% | 22.17% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.46 | 0.46 |
P/E ratio | 15.67 | 32.41 |
Last price | $94.85 | $347.68 |
Inception | — | — |
Issuer | iShares | Vanguard |
ITB top holdings
| DHI | D.R. Horton Inc | 17.94% |
| PHM | PulteGroup Inc | 11.29% |
| LEN | Lennar Corp Class A | 8.13% |
| NVR | NVR Inc | 7.28% |
| TOL | Toll Brothers Inc | 4.72% |
| HD | The Home Depot Inc | 4.51% |
| LOW | Lowe's Companies Inc | 4.47% |
| SHW | Sherwin-Williams Co | 4.41% |
| MAS | Masco Corp | 3.43% |
| IBP | Installed Building Products Inc | 2.45% |
VHT top holdings
| LLY | Eli Lilly and Co | 12.93% |
| JNJ | Johnson & Johnson | 8.78% |
| ABBV | AbbVie Inc | 6.45% |
| MRK | Merck & Co Inc | 5.01% |
| UNH | UnitedHealth Group Inc | 4.65% |
| TMO | Thermo Fisher Scientific Inc | 3.50% |
| AMGN | Amgen Inc | 3.18% |
| GILD | Gilead Sciences Inc | 2.58% |
| ABT | Abbott Laboratories | 2.40% |
| PFE | Pfizer Inc | 2.27% |
About ITB
ITB (iShares US Home Construction ETF) is US homebuilding and construction companies. Managed by iShares, the fund carries $2.4B in assets under management, an expense ratio of 0.37%, a dividend yield of 1.36%. Its largest holding is D.R. Horton Inc (DHI), which represents 17.9% of the portfolio. Real Estate is the fund's largest sector exposure at 0.6%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $23.7B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.35%. Its largest holding is Eli Lilly and Co (LLY), which represents 12.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.